Undruggable Targets

Boulder, Colorado, January 20, 2026 — Think Bioscience, a privately held biotechnology company focused on unlocking historically “undruggable” drug...

Cambridge, Massachusetts — January 8, 2026 — Parabilis Medicines announced the successful close of an oversubscribed $305 million Series...